Who influenced WHO?
Is it better to overestimate the threat of a virus and spend millions on vaccines that may not be needed, or make a misjudgment in the other direction and cause millions of unnecessary deaths? By Jodie Humphries
The pharmaceutical supply chain
Tightening the security of the pharmaceutical supply chain is becoming a key issue for the industry. The fight to avoid contaminated ingredients finding their way into medicines is hotting up, with the formation of a new international consortium now having received its European debut.
The growth of generic drug companies
As one door closes, another opens. And over the next few years, as drug patent expiries heat up, those that will profit most will be the generic drug companies, marking a new direction for the pharmaceutical industry.
Drug patent problem rocks AstraZenenca
At the end of last week, the chief executive of AstraZeneca unveiled a 27 percent jump in pre-tax profits for the third quarter. But, with drug patents facing expiration - currently one of the pharmaceutical industry's biggest challenges - just around the corner, it's far from an easy ride for the company.
Faking It
Travis Johnson of International Anti-Counterfeiting Coalition talks to NGP about the global problem of counterfeit pharmaceuticals.
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.